|
Leflunomide Clinical Trials
7 actively recruiting trials across 3 locations
Also known as: Arava, LEF, SU101
Pipeline
Phase 1: 3Phase 2: 2Phase 3: 1Phase 4: 1
Top Sponsors
- City of Hope Medical Center3
- University of Nebraska1
- Qilu Hospital of Shandong University1
- N.N. Petrov National Medical Research Center of Oncology1
- Deborah Doroshow1
Indications
- Cancer5
- Arthritis2
- PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer1
- Advanced Pancreatic Adenocarcinoma1
- Refractory Plasma Cell Myeloma1
Duarte, California3 trials
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
City of Hope Medical Center
Phase 1
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
City of Hope Medical Center
Phase 1
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
City of Hope Medical Center
Phase 2
Other2 trials
Omaha, Nebraska1 trial
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
University of Nebraska Medical Center
Phase 3
New York, New York1 trial
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer
Icahn School of Medicine at Mount Sinai
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.